Eichenfield Lawrence 4
4 · Verrica Pharmaceuticals Inc. · Filed Aug 3, 2020
Insider Transaction Report
Form 4
Eichenfield Lawrence
Director
Transactions
- Award
Stock Option (right to buy)
2020-08-01+17,502→ 17,502 totalExercise: $6.56Exp: 2030-07-31→ Common Stock (17,502 underlying)
Footnotes (1)
- [F1]1/3rd of the total shares subject to the option shall vest on August 1, 2021 and 1/36th of the total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.